Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
Cerilliant
UBS
Federal Trade Commission
Johnson and Johnson
Moodys
Citi
US Department of Justice

Generated: August 21, 2018

DrugPatentWatch Database Preview

Beclomethasone dipropionate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for beclomethasone dipropionate and what is the scope of beclomethasone dipropionate patent protection?

Beclomethasone dipropionate is the generic ingredient in eleven branded drugs marketed by Glaxosmithkline, Teva Branded Pharm, Norton Waterford, and Schering, and is included in eleven NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Beclomethasone dipropionate has two hundred and forty-eight patent family members in thirty-one countries.

There are twenty drug master file entries for beclomethasone dipropionate. Five suppliers are listed for this compound.

Pharmacology for beclomethasone dipropionate
Synonyms for beclomethasone dipropionate
(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione
(11beta,16beta)-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-chloro-17-hydroxy-2,13,15-trimethyl-5-oxo-14-(propanoyloxy)tetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-14-yl]-2-oxoethyl propanoate
2-[(1R,2S,10S,11S,13S,14R,15S,17S)-1-CHLORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXO-14-(PROPANOYLOXY)TETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL PROPANOATE
32278-EP2281815A1
32278-EP2295408A1
32278-EP2301933A1
32278-EP2305640A2
32278-EP2311827A1
34135-07-4
534B098
5534-09-8
5B307S63B2
9-AE-11|A,17,21-EyoC>>u-16|A-(1/4)x>>uOEthcThorn-1,4- paragraph signthornI(c)-3,20- paragraph signthornI feminine-17,21- paragraph signthorn+/-uEao yen
9-Chloro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta, 17,21-trihydroxy-16 beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-chloro-16beta-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-dipropionate
AB1009261
AC-2159
AC1L2IWA
AC1Q62MZ
Aerobec
AKOS015951275
Alanase
Aldecin
Aldecina
Aldecine
Ambap5534-09-8
AN-14214
API0001601
Atomase
B4464
Beclacin
Beclate
Beclazone
Beclazone 250
Beclocort Nasel
Becloforte
Beclomet
Beclomet Nasal
Beclometasone 17,21-dipropionate
Beclometasone dipropionate
Beclometasone dipropionate (JP17)
Beclometasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard
Beclometasone dipropionate for system suitability, European Pharmacopoeia (EP) Reference Standard
Beclometasone dipropionato
Beclomethasone dipropionate (USP)
Beclomethasone dipropionate [USAN:USP]
Beclomethasone dipropionate [USAN]
BECLOMETHASONE DIPROPIONATE MONOHYDRATE
Beclomethasone dipropionate, analytical standard, for drug analysis
Beclomethasone dipropionate, anhydrous, European Pharmacopoeia (EP) Reference Standard
Beclomethasone Dipropionate, pharmaceutical secondary standard, traceable to USP, PhEur, BP
Beclomethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
Beclorhinol
Becloturmant
Beclovent
Beclovent (TN)
Beconase
Beconase AQ
Benconase
BPBio1_000957
BRD-K97810537-001-03-7
BSPBio_000869
C07813
C28H37ClO7
CAS-5534-09-8
CCG-220855
CHEBI:3002
CHEMBL1200500
Clenil
Clenil-A
CPD001233361
CS-1503
CTK8F7938
D00689
DSSTox_CID_28656
DSSTox_GSID_48730
DSSTox_RID_82926
DTXSID3048730
EINECS 226-886-0
Entyderma
GTPL5894
HMS1570L11
HMS2097L11
HMS2235O23
HMS3259H03
HY-13571A
Inalone O
Inalone R
Korbutone
KUVIULQEHSCUHY-XYWKZLDCSA-N
KW-053
LS-118439
Menaderm
MFCD00135613
MLS002154034
MolPort-003-983-412
NC00610
NCGC00094596-03
NCGC00179392-01
PL000448
Pregna-1-4-diene-3,20-dione, 9-chloro-16-beta-methyl-11-beta,17,21-trihydroxy-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 9-chloro-16-beta-methyl-11-beta,17,21-trihydroxy-, 17,21-dipropionate
Prestwick_990
Prestwick0_000855
Prestwick1_000855
Prestwick2_000855
Prestwick3_000855
Propaderm
Propaderm Forte
Propionic acid beclomethasone
QNASL
Qnasl (TN)
Qvar
QVAR 40
Qvar 80
Respocort
Rhino Clenil
Rhinosol
Rino-clenil
s3078
Sanasthmax
Sanasthmyl
SCH 18020W
SCHEMBL6890
SMR001233361
SPBio_002790
Spir
ST24046007
Tox21_113168
Turbinal
UNII-5B307S63B2
Vancenase
Vanceril
Vanceril (TN)
Vanceril Double Strength
Ventolair
Viarox
W-5080
ZINC3938744

US Patents and Regulatory Information for beclomethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Norton Waterford QVAR REDIHALER beclomethasone dipropionate AEROSOL, METERED;INHALATION 207921-001 Aug 3, 2017 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Schering VANCERIL beclomethasone dipropionate AEROSOL, METERED;INHALATION 017573-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Teva Branded Pharm QNASL beclomethasone dipropionate AEROSOL, METERED;NASAL 202813-002 Dec 17, 2014 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for beclomethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm QNASL beclomethasone dipropionate AEROSOL, METERED;NASAL 202813-001 Mar 23, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QNASL beclomethasone dipropionate AEROSOL, METERED;NASAL 202813-002 Dec 17, 2014 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for beclomethasone dipropionate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,978,966 Dose counters for inhalers, inhalers and methods of assembly thereof ➤ Try a Free Trial
9,108,010 Dose counters for inhalers, inhalers and methods of assembly thereof ➤ Try a Free Trial
9,174,013 Dose counters for inhalers, inhalers and methods of assembly thereof ➤ Try a Free Trial
9,216,260 Dose counters for inhalers, inhalers and methods of assembly thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Daiichi Sankyo
QuintilesIMS
Accenture
Cerilliant
Fish and Richardson
Queensland Health
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.